Award
National Institute of Dental and Craniofacial Research 5R01DE033583-03
Optimization of a Treatment for Sjögren's Disease Using Aspirin-Triggered Resolvin D1 and Dexamethasone
Recipient
National Institute of Dental and Craniofacial Research
Award Amount
$489,587.00
Ceiling
$489,587.00
Awarded
December 05, 2025
Identifier
5R01DE033583-03
NIH funded research project to optimize treatment for Sjögren's Disease using aspirin-triggered resolvin D1 and dexamethasone.
Description
This is a research project funded by NIH, focusing on developing a therapeutic approach for Sjögren's Disease using aspirin-triggered resolvin D1 and dexamethasone. The project aims to optimize dosage and understand mechanisms of treatment outcomes.